Asaya has raised Rs 88 crore in a Series A that values the skincare company at Rs 400 crore post-money — roughly triple its valuation from eleven months ago, and a sign that Indian consumer investors are still writing cheques for D2C brands that can point to contribution-level profits rather than only to growth.

The round, announced on August 24, 2026, was led by RPSG Capital and works out to about $9.2 million. OTP Ventures, Huddle Ventures, Hyperscale Ventures and 72 Ventures participated. It follows a Rs 28 crore (roughly $3 million) pre-Series A in September 2025, also led by RPSG Capital, and is the Bengaluru-based company's second institutional round. Asaya was founded in 2021 by Neeraj Biyani, Eeti Sharma and Mandeep Singh Bhatia, and operates under Wellspring Consumer Private Limited. Proceeds go to research and development, product expansion, distribution and hiring, with about a fifth earmarked for R&D and plans to double the team.

What the company sells

Asaya makes skincare formulated for melanin-rich skin, with hyperpigmentation as its central problem statement — dark spots, uneven tone, post-acne marks — across both face and body. The catalogue runs to serums, creams, cleansers, sunscreens and body sprays, and the brand's differentiator is MelaMe, a proprietary complex it developed for pigmentation on Indian skin types. Distribution is spread across its own site, marketplaces including Nykaa, Amazon, Flipkart, Myntra, Tira and Purplle, and quick-commerce apps Blinkit, Zepto, Swiggy Instamart and BigBasket. It also sells into the United States and the UAE through Amazon.

The numbers behind the round

The company says revenue has grown 16 times since the pre-Series A and that it now runs at an annualised revenue run rate of about Rs 100 crore, on a base that was Rs 96 lakh in FY24, its first eight months of selling. Its website reaches more than 18,000 pin codes, with over 2,000 eligible for 24-hour delivery. Management describes the business as variable contribution-level profitable and has set a target of Rs 200 crore in ARR within 18 months. Those figures are company-stated and unaudited, which is the usual caveat for a private brand at this stage; what is externally verifiable is the price. Rs 400 crore post-money against a round done eleven months earlier implies investors marked the company up roughly threefold, and RPSG Capital doubled down rather than letting a new lead set the terms.

Why the timing matters

Indian beauty and personal care has been the most crowded corner of D2C for five years, and most of the funding has gone to brands competing on assortment and celebrity marketing. Asaya is a narrower bet: one skin concern, a claimed proprietary molecule, and a customer whose needs mass Western formulations have historically ignored. That is a defensible wedge as long as the science holds up, and it explains why a fifth of the round goes back into the lab.

The harder test is channel. Quick commerce has let brands like this reach national scale without a distributor network, but it compresses margin and hands shelf logic to an algorithm. Asaya had earlier said it would move into physical retail once it crossed Rs 50 crore in ARR — it is now past that mark, and offline entry is on the table. Getting from Rs 100 crore to Rs 200 crore ARR through general trade and modern retail is a different operating problem than growing on Blinkit, and it is the one this Rs 88 crore is meant to pay for.

Source

Entrackr — "D2C skincare brand Asaya raises Rs 88 Cr from RPSG Capital, OTP Ventures, others"